Pharma pledges help on patient access to chronic-disease meds

Drugmakers are pledging to help revamp drug distribution and grapple with other obstacles to patient access to medicines in developing countries, the Financial Times reports. Prices aren't the issue, companies say, but rather infrastructure. Report

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.